Live Breaking News & Updates on Department of gastrointestinal medical oncology

Stay informed with the latest breaking news from Department of gastrointestinal medical oncology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Department of gastrointestinal medical oncology and stay connected to the pulse of your community

Bristol Myers: cancer treatment results -April 09, 2024 at 09:52 am EDT

Bristol Myers announces that KRAZATI in combination with cetuximab demonstrates clinically meaningful activity as a targeted treatment option for patients with previously treated locally advanced or...

Texas , United-states , American , Anne-kerber , Scott-kopetz , Bristol-myers , American-association-for-cancer-research , Department-of-gastrointestinal-medical-oncology , Head-of-late-stage-clinical-development , Bristol-myers-squibb , University-of-texas-md-anderson-cancer-center , American-association

Dr Overman on Nonoperative Cancer Management in GI Malignancies

Michael J. Overman, MD, discusses the rationale for utilizing a nonoperative management approach over traditional surgery in gastrointestinal cancers.

Texas , United-states , Michaelj-overman , Division-of-cancer-medicine , Department-of-gastrointestinal-medical-oncology , Md-anderson-cancer-network , University-of-texas-md-anderson-cancer-center , Gastrointestinal-medical-oncology , Cancer-medicine , Executive-committee , Medical-staff

KRAZATI (adagrasib) in Combination with Cetuximab Demonstrates Clinically Meaningful Activity as a Targeted Treatment Option for Patients with Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer (CRC)

Late-breaking data to be featured in an oral presentation at the American Association for Cancer Research annual meeting on Monday, April 8 and highlighted as part of the official meeting press...

United-states , Texas , American , Scott-kopetz , Anne-kerber , Bristol-myers-squibb , American-association-for-cancer-research , Twitter , European-commission , Exchange-commission , Youtube , University-of-texas-md-anderson-cancer-center

CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee -March 28, 2024 at 03:22 pm EDT

– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from...

Dana-farber-cancer-institute , Massachusetts , United-states , Hebron , Israel-general- , Israel , Montefiore , Yerushalayim , Texas , Colorado , Boston , Germany

AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee

AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Dana-farber-cancer-institute , Massachusetts , United-states , Hebron , Israel-general- , Israel , Colorado , Montefiore , Yerushalayim , Germany , Boston , Texas

Dr Overman on the Potential Use of Endoscopy and ctNDA in Nonoperative GI Cancer Management

Michael J. Overman, MD, discusses the potential use of endoscopy and ctDNA to guide nonoperative management approaches in gastrointestinal cancers.

Texas , United-states , Michaelj-overman , Md-anderson-cancer-network , University-of-texas-md-anderson-cancer-center , Division-of-cancer-medicine , Department-of-gastrointestinal-medical-oncology , Gastrointestinal-medical-oncology , Cancer-medicine , Executive-committee , Medical-staff

"Interventions Are Needed at Every Step"

MD Anderson's Ryan Huey, MD, offers a survey of research on a holistic approach to addressing financial toxicity during Patient Centered Oncology Care 2023.

Houston , Texas , United-states , California , North-carolina , Texas-medical-center , Ryan-huey , Department-of-gastrointestinal-medical-oncology , Atrium-health-levine-cancer-institute-in-charlotte , University-of-texas-md-anderson-cancer-center , Lazarex-cancer-foundation , Gastrointestinal-medical-oncology

Presence of ctDNA Does Not Predict Benefit of Adjuvant Chemotherapy in Stage II Colon Cancer

Adjuvant chemotherapy did not improve circulating tumor DNA clearance in patients with stage II colon cancer with baseline circulating tumor DNA.

Houston , Texas , United-states , Vank-morris , Department-of-gastrointestinal-medical-oncology , University-of-texas-md-anderson-cancer-center , Morris , Gastrointestinal-medical-oncology , Cancer-center , Adjuvant-chemotherapy , Patients-with-low-risk

Vaccine shows promise as treatment for colorectal, pancreatic cancer

Researchers say a vaccine with a new drug performed well in a clinical trial at preventing the recurrence of pancreatic and colorectal cancer

California , United-states , Stanford-university , Texas , American , Christina-annunziata , Christopher-chen , Early-drug-development-program-at-stanford-university , American-cancer-society , Department-of-gastrointestinal-medical-oncology , University-of-texas-md-anderson-cancer-center , Nature-medicine

Dr Morelli on the Ongoing Investigation of A2B530 in Advanced or Metastatic Solid Tumors

Maria Pia Morelli, MD, PhD, discusses the ongoing investigation of A2B530, a Tmod™ CAR T-cell therapy, in advanced or metastatic solid tumors and highlights forward-facing research with the agent.

Texas , United-states , Maria-pia-morelli , Division-of-cancer-medicine , Department-of-gastrointestinal-medical-oncology , University-of-texas-md-anderson-cancer-center , Gastrointestinal-medical-oncology , Cancer-medicine , Cancer-center , Onclive-tv ,